Lexeo Therapeutics (LXEO)

• Market cap: $412M
• 1 day: -2.42%
• 5 days: -16.54%
• 1 month: -10.17%
• 3 months: -46.85%
• 6 months: 6.4%
• Year to date: -41.21%
• 1 year: 110.04%
• 5 years: -43.78%
• 10 years: -43.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Employees: 75